FDA product code OWD: Somatic Gene Mutation Detection System
OWD is the FDA product code for somatic gene mutation detection system. It is a Class III device, reviewed by the Pathology panel. Devices under OWD reach the market by PMA; FDA lists no cleared 510(k)s for it. 19 PMA applications cite this product code. FDA has posted 13 recalls for OWD devices, 6 initiated in the last five years.
Definition
The somatic gene mutation detection system is an in vitro diagnostic nucleic acid amplification and real-time detection system for the identification of genetic mutations in DNA extracted from human tumor tissues.
Classification
| Field | Value |
|---|---|
| Device name | Somatic Gene Mutation Detection System |
| Device class | Class III |
| Review panel | PA — Pathology |
| Medical specialty | Unknown |
| Premarket route | PMA |
Recalls for OWD devices
13 product recalls in 10 recall events; 6 initiated in the last five years and 7 still open. Most recent: 2023-08-22.
| Year | Recalls |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 5 |
| 2023 | 1 |
Frequently asked questions
What is FDA product code OWD?
OWD is the FDA product code for somatic gene mutation detection system. It is a Class III device, reviewed by the Pathology panel.
What device class is OWD?
Class III. Typical premarket route: PMA.
Have OWD devices been recalled?
Yes: 13 product recalls across 10 recall events; the most recent began 2023-08-22.
Next steps
- Run an FDA pathway report with predicate devices for product code OWD
- Run a recall and safety report across every OWD manufacturer
- Watch product code OWD for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Pathology product codes · FDA product code lookup · 510(k) database search · 510(k) review times